Telmisartan in the diabetic murine model of acute myocardial infarction: dual contrast manganese-enhanced and delayed enhancement MRI evaluation of the peri-infarct region.

MLA

Toma, Ildiko, et al. “Telmisartan in the Diabetic Murine Model of Acute Myocardial Infarction: Dual Contrast Manganese-Enhanced and Delayed Enhancement MRI Evaluation of the Peri-Infarct Region.” Cardiovascular Diabetology, vol. 15, Feb. 2016, pp. 1–12. EBSCOhost, https://doi.org/10.1186/s12933-016-0348-y.

APA

Toma, I., Kim, P. J., Dash, R., McConnell, M. V., Nishimura, D., Harnish, P., & Yang, P. C. (2016). Telmisartan in the diabetic murine model of acute myocardial infarction: dual contrast manganese-enhanced and delayed enhancement MRI evaluation of the peri-infarct region. Cardiovascular Diabetology, 15, 1–12. https://doi.org/10.1186/s12933-016-0348-y

Chicago

Toma, Ildiko, Paul J. Kim, Rajesh Dash, Michael V. McConnell, Dwight Nishimura, Phillip Harnish, and Phillip C. Yang. 2016. “Telmisartan in the Diabetic Murine Model of Acute Myocardial Infarction: Dual Contrast Manganese-Enhanced and Delayed Enhancement MRI Evaluation of the Peri-Infarct Region.” Cardiovascular Diabetology 15 (February): 1–12. doi:10.1186/s12933-016-0348-y.